Beijing Hotgen Biotech Co., Ltd. (688068.SS) SHH

81.00

-4.82(-5.62%)

Updated at June 02 03:00PM

Currency In CNY

Valuation

Market Cap15.22B
Enterprise Value14.74B
P/E Ratio-28.12
PEG Ratio1.18
Price/Sales Ratio17.45
Price/Book Ratio2.94
Enterprise/Revenue17.2
Enterprise/EBITDA-28.47

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.59
Operating Margin-0.75

Management Effectiveness

Return On Assets-0.08
Return On Equity-0.09

Income Statement

Revenue404.88M
Revenue/Share4.87
Gross Profit407.69M
EBITDA-189.01M
Net Income-210.52M
Diluted EPS-2.24

Balance Sheet

Total Cash1.21B
Total Cash/Share13.73
Total Debt3.8M
Total Debt/Equity0
Current Ratio6.74
Book Value Per Share29.32

Price History

52-Week Change-38.64
52-Week High262.22
52-Week Low74.77
Moving Average 50 Days110.08
Moving Average 200 Days150.16

Statistics

Average Volume2.43M
Shares Outstanding92.75M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0
Last Split Factor37:25
Last Split DateJune 16, 2022